34
Participants
Start Date
February 28, 2010
Primary Completion Date
June 30, 2012
Study Completion Date
August 31, 2020
regorafenib
Taken orally, once a day in the morning for 3 weeks followed by a one week rest period
Fox Chase Cancer Center, Philadelphia
Oregon Health Sciences University, Portland
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Collaborators (1)
Brigham and Women's Hospital
OTHER
Massachusetts General Hospital
OTHER
Fox Chase Cancer Center
OTHER
Oregon Health and Science University
OTHER
Bayer
INDUSTRY
Suzanne George, MD
OTHER